Since 1977, OSYPKA AG has operated as an internationally renowned manufacturer and partner in the development, production, and distribution of active implants, electrodes, and catheters.

In the area of temporary cardiac stimulation and interventional cardiology, OSYPKA AG provides its own solutions designed for users' needs.

Additionally, we are partners of medical technology companies across Europe, Japan, and the USA, contributing to the development and production of active implants (with a focus on neurostimulation), implantable electrodes, and complex catheter systems.

Am Standort in Rheinfelden/Deutschland verfügen wir über 7.720 m² Gebäudefläche, in welchen sich Büros und Produktionsbereiche, sowie Reinräume der Klasse 7 befinden.

With a highly specialized team and years of technical expertise, we have achieved a high level of vertical integration, allowing for comprehensive solutions from a single source. This strategic approach makes us almost entirely independent of supply chains, brings considerable cost savings, and accelerates market launches.